Copyright
©The Author(s) 2019.
World J Gastroenterol. Nov 14, 2019; 25(42): 6311-6321
Published online Nov 14, 2019. doi: 10.3748/wjg.v25.i42.6311
Published online Nov 14, 2019. doi: 10.3748/wjg.v25.i42.6311
Figure 4 Overexpression of miR-30c inhibits tumor growth in vivo.
A: Images of the xenograft model from each treated group. B: Tumor growth curves of each treated group in mice (n = 5) inoculated with the indicated cells on the indicated days. C: Tumor weight of each treated group. D: H&E staining and immunohistochemistry analysis of Ki-67 and twinfilin 1 (TWF1) in each treated group. Scale bar, 50 μm (red line). E and F: Quantitative real-time polymerase chain reaction analysis of miR-30c and TWF1 expression in xenograft tumors of the indicated group. The data are presented as the mean ± standard deviation. P < 0.05 was considered statistically significant. eP < 0.001 vs control group. TWF1: Twinfilin 1.
- Citation: Sun LL, Cheng M, Xu XD. MicroRNA-30c inhibits pancreatic cancer cell proliferation by targeting twinfilin 1 and indicates a poor prognosis. World J Gastroenterol 2019; 25(42): 6311-6321
- URL: https://www.wjgnet.com/1007-9327/full/v25/i42/6311.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i42.6311